V

Veru
D

VERU

0.56250
USD
-0.04
(-6.23%)
مغلق
حجم التداول
0
الربح لكل سهم
-0
العائد الربحي
-
P/E
-3
حجم السوق
82,453,455
أصول ذات صلة
A
ALT
-0.02500
(-0.61%)
4.07500 USD
A
AQST
-0.05500
(-1.31%)
4.15000 USD
D
DRRX
0.00990
(1.74%)
0.57990 USD
S
SND
-0.06000
(-2.87%)
2.03000 USD
T
TNXP
4.990
(11.16%)
49.710 USD
المزيد
الأخبار المقالات

العنوان: Veru

القطاع: Healthcare
الصناعة: Biotechnology
Veru Inc is a biopharmaceutical company with a drug development program for the treatment of metabolic diseases, oncology, and acute respiratory distress syndrome (ARDS). The company is also in the late-stage development of certain drugs for the management of breast and prostate cancers. It also has a sexual health program that includes two products, ENTADFI, for the treatment of benign prostatic hyperplasia (BPH) and the FC2 Female Condom (Internal Condom). The company operates in a single segment and generates revenue from the USA which is the key revenue generating market, Brazil, and other regions.